This company seems to have been delisted
Reason: Rebranded as Talphera
Last recorded trade on: March 13, 2024
Source: https://www.fiercepharma.com/marketing/acelrx-becomes-talphera-adopting-new-name-reflect-pain-pivot
Reason: Rebranded as Talphera
Last recorded trade on: March 13, 2024
Source: https://www.fiercepharma.com/marketing/acelrx-becomes-talphera-adopting-new-name-reflect-pain-pivot
AcelRx Pharmaceuticals
ACRX
$1.50
Share price
7.50%
Change (1 day)
48.16%
Change (1 year)
Categories
AcelRx Pharmaceuticals (ACRX) - Total assets
Total assets on the balance sheet as of December 2023 : NZ$35.67 Million
According to AcelRx Pharmaceuticals 's latest financial reports the company's total assets are NZ$35.67 Million. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
AcelRx Pharmaceuticals - Total assets on balance sheet (from 2009 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | NZ$74.79 M | -34.41% |
| 2021-12-31 | NZ$0.11 B | 24.12% |
| 2020-12-31 | NZ$91.87 M | -32.27% |
| 2019-12-31 | NZ$0.13 B | -24.51% |
| 2018-12-31 | NZ$0.17 B | 68.91% |
| 2017-12-31 | NZ$0.10 B | -26.31% |
| 2016-12-31 | NZ$0.14 B | -22.68% |
| 2015-12-31 | NZ$0.18 B | 69.22% |
| 2014-12-31 | NZ$0.11 B | -17.6% |
| 2013-12-31 | NZ$0.13 B | 70.72% |
| 2012-12-31 | NZ$78.43 M | 49.9% |
| 2011-12-31 | NZ$52.32 M | 491% |
| 2010-12-31 | NZ$8.85 M | -55.63% |
| 2009-12-31 | NZ$19.95 M | -48.95% |
| 2008-12-31 | NZ$39.08 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | NZ$76.66 M | 114.89% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |